Denali Therapeutics Inc. Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Denali Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • Denali Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -30 %, a 227% decline year-over-year.
  • Denali Therapeutics Inc. annual Return On Assets for 2023 was -11.4 %, a 53.7% increase from 2022.
  • Denali Therapeutics Inc. annual Return On Assets for 2022 was -24.6 %, a 25.1% decline from 2021.
  • Denali Therapeutics Inc. annual Return On Assets for 2021 was -19.7 %, a 378% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -11.4 +13.2 +53.7% Jan 1, 2023 Dec 31, 2023
2022 -24.6 -4.94 -25.1% Jan 1, 2022 Dec 31, 2022
2021 -19.7 -26.7 -378% Jan 1, 2021 Dec 31, 2021
2020 7.08 +39.1 Jan 1, 2020 Dec 31, 2020
2019 -32 -25.9 -428% Jan 1, 2019 Dec 31, 2019
2018 -6.06 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.